检索结果 - Mahmoud Abbas

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma

    Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma 由 Kai Gebauer, Inga Peters, Natalia Dubrowinskaja, Jörg Hennenlotter, Mahmoud Abbas, Ralph Scherer, Hossein Tezval, Axel S. Merseburger, Arnulf Stenzl, M.A. Kuczyk, Jürgen Serth

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies

    DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies 由 Inga Peters, Natalia Dubrowinskaja, Mahmoud Abbas, Christoph Seidel, Michael Kogosov, Ralph Scherer, Kai Gebauer, Axel S. Merseburger, Markus A. Kuczyk, Viktor Grünwald, Jürgen Serth

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    <i>Neurofilament Heavy polypeptide</i> CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response

    <i>Neurofilament Heavy polypeptide</i> CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy res... 由 Natalia Dubrowinskaja, Kai Gebauer, Inga Peters, Jörg Hennenlotter, Mahmoud Abbas, Ralph Scherer, Hossein Tezval, Axel S. Merseburger, Arnulf Stenzl, Viktor Grünwald, Markus A. Kuczyk, Jürgen Serth

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)

    TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN... 由 Viktor Grünwald, Ulrich Keilholz, Andreas Boehm, Orlando Guntinas‐Lichius, B. Hennemann, Hans‐Joachim Schmoll, Philipp Ivanyi, Mahmoud Abbas, U. Lehmann, Andreas Koch, Annika Karch, A. Zörner, Thomas Gauler

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Medication Adherence Among Patients with Multimorbidity in the United Arab Emirates

    Medication Adherence Among Patients with Multimorbidity in the United Arab Emirates 由 Allaham, Kholoud K, Feyasa, Merga Belina, Govender, Romona Devi, Musa, Anas Mahmoud Abbas, AlKaabi, Ahmed Juma, ElBarazi, Iffat, AlSheryani, Shamma Dahi, Al Falasi, Reem Juma, Khan, Moien A B

    出版 2022
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

    Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance 由 Niklas Klümper, Damian J. Ralser, Jörg Ellinger, Florian Roghmann, Julia Albrecht, Eduard Below, Abdullah Alajati, Danijel Sikic, Johannes Breyer, Christian Bolenz, Friedemann Zengerling, Philipp Erben, Kristina Schwamborn, Ralph M. Wirtz, Thomas Horn, Dora Nagy, Marieta Toma, Glen Kristiansen, Thomas Büttner, Oliver Hahn, Viktor Grünwald, Christopher Darr, Eva Erne, Steffen Rausch, Jens Bedke, Katrin Schlack, Mahmoud Abbas, Stefanie Zschäbitz, Constantin Schwab, Alexander Mustea, Patrick Adam, Andreas Manseck, Bernd Wullich, Manuel Ritter, Arndt Hartmann, Jürgen E. Gschwend, Wilko Weichert, Franziska Erlmeier, Michael Hölzel, Markus Eckstein

    出版 2022
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  7. 7
    <i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

    <i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer 由 Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Günter Niegisch, Camilla M. Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß‐Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Jörg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J. Meeks, Francisco Vera-Badillo, J. Alberto Nakauma-González, Joost L. Boormans, Kerstin Junker, Arndt Hartmann, Viktor Grünwald, Michael Hölzel, Markus Eckstein

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: